Methods for prevention and treatment of attention deficit disorder
Patent 5885998 Issued on March 23, 1999. Estimated Expiration Date: February 12, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/256, 1,3-diazines (e.g., pyrimidines, etc.)514/277, Hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/344, Cyano bonded directly to the six-membered hetero ring514/357Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding
Patients susceptible to or suffering from attention deficit disorder are treated by administering an effective amount of an aryl subsistituted aliphatic compound, an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound. Exemplary compounds are (E)-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-4-3-(5-methoxypyridin)yl!-3-butene-1-amine, (E)-N-methyl-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-N-methyl-4-3-(5-methoxypyrindin)yl!-3-butene-1-amine, (Z)-metanicotine, (E)-metanicotine, N-methyl-(3-pyridinyl)-butane-1-amine, N-methyl-4-(3-pyridinyl)-3-butyne-1-amine and (E)-N-methyl-4-3-(6-methylpyrindin)yl!-3-butene-1-amine.
Other References
Adler, L. et al., "Normalization by Nicotine of Deficient Auditory Sensory Gating in the Relative Schizophrenics", Biol. Psychiatry, vol. 32, pp. 607-616 (1992)
Calderon-Gonzalez R., "Tourette Syndrome", Intern. Pediat., vol. 8(2), pp. 176-188 (1993)
Decina, P. et al., "Cigarette Smoking and Neuroleptic-Induced Parkinsonism", Biol. Psychiatry, 28, pp. 502-508 (1990)
Devor, E. et al., "Nicotine and Tourette's Syndrome", The Lancet, vol. 8670, p. 1046 (1989)
Faraone, S. et al., "An Exploratory Study of ADHD among Second-Degree Relatives of ADHD Children", Biol. Psychiatry, vol. 35(6), pp. 398-402 (1994)
Glassman, A., "Cigarette Smoking: Implications for Psychiatric Illness", Am J Psychiatry, vol. pp. 546-553 (1993)
Hall, G. et al., Effects of Nicotine on the Release of 3 H-Noradrenaline from the Hypothalamus Biochemical Pharmacology, vol. 21, pp. 1829-1838 (1972)
Harsing, L. et al., "Dopamine Efflux from Striatum After Chronic Nicotine: Evidence for Autore Desensitization", Journal of Neurochemistry, vol. 59, pp. 48-54 (1993)
Hery, F. et al., "Control of the Release of Newly Synthesized 3 H-5-Hydroxytryptamine by Nicotine and Muscarinic Receptors in Rat Hypothalamic Slices", Arch. Int. Pharmacodyn. Ther., vol. 29, 91-97 (1977)
Jarvik, M. "Beneficial effects of nicotine", British Journal of Addiction, vol. 86, pp. 571-575 (1991)
Lieberman, J. et al., "Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review", Schizophr. Bull., vol. 19, pp. 371-429 (1993)
Malone, M. et al., "Hemispheric Processing and Methylphenidate Effects in Attention-Deficit Hyperactivity Disorder", J. Child Neurol., vol. 9(2), pp. 181-189 (1994)
Hughes, "Proceedings from Intl. Symp. Nic.", S40 (1994)
McConville, B. et al., "Nicotine Potentiation of Haloperidol in Reducing Tic Frequency in Tourette's Disorder", Am. J. Psychiatry, vol. 148, pp. 793-794 (1991)
McConville, B. et al., "The Effects of Nicotine Plus Haloperidol Compared to Nicotine Only and Placebo Nicotine Only in Reducing Tic Severity and Frequency in Tourette's Disorder", Biol. Psychiatry, vol. 31, pp. 832-840 (1992)
Newhouse, P. et al., "The role of nicotine and nicotinic mechanisms in neuropsychiatric disease", British Journal of Addiction, vol. 86, pp. 521-526 (1991)
Onaivi, E. et al., "Chronic Nicotine Reverses Age-Associated Increases in Tail-Flick Latency and Anxiety in Rats", Life Sciences, vol. 54, pp. 193-202 (1994)
Perry, E., "The Cholinergic Hypothesis-Ten Years On", British Medical Bulletin, vol. 42, pp. 63-69 (1986)
Rapier, C. et al., "Stereoselective Nicotine-Induced Release of Dopamine from Striatal Synaptosomes: Concentration Dependence and Repetitive Stimualtion", Journal of Neurochemistry, vol. 50, pp. 1123-1130 (1988)
Rowell, P. et al., "Nicotinic Stimulation of 3 H! Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes", Journal of Neurochemistry, vol. 43, pp. 1593-1598 (1984)
Sanberg, P. et al., "Nicotine Potentiation of Haloperidol-Induced Catalepsy: Striatal Mechanisms", Pharmacology Biochemistry and Behavior, vol. 46, pp. 303-307 (1993)
Sandor, N. et al., "Effect of nicotine on dopaminergic-cholinergic interaction in the striatum", Brain Research, vol. 567, pp. 313-316 (1991)
Sitaram, N. et al., "Human Serial Learning: Enhancement with Arecholine and Choline and Impairment with Scopolamine", Science, vol. 201, pp. 274-276 (1978)
Sjak-Shie, N. et al., "Effects of chronic nicotine and pilocarpine administration on neocortical neuronal density and 3 H! GABA uptake in nucleus basalis lesioned rats", Brain Research, vol. 624, pp. 295-298 (1993)
Toth, E. et al., "Effect of Nicotine on Extracellular Levels of Neurotransmitters Assessed by Microdialysis in Various Brain Regions: Role of Glutamic Acid", Neurochemical Research, vol. 17(3), pp. 265-271 (1992)
Vizi, E., "Acetylcholine release from guinea-pig ileum by parasympathetic ganglion stimulants and gastrin-like polypeptides", British Journal Pharmacology, vol. 47, pp. 765-777 (1973)
Physicians' Desk Reference, 48 Edition, pp. 410-411 (1994), "Cylert"
Physicians' Desk Reference, 48 Edition, pp. 520-523 (1994), "Prolixin"
Physicians' Desk Reference, 48 Edition, pp. 612-614 (1994), "Catapres"
Physicians' Desk Reference, 48 Edition, pp. 835-836 (1994), "Ritalin"
Physicians' Desk Reference, 48 Edition, pp. 977-979 (1994), "Orap"
Physicians' Desk Reference, 48 Edition, pp. 1357-1359 (1994), "Haldol"
Physicians' Desk Reference, 48 Edition, pp. 1935-1936 (1994), "Klonopin"
Physicians' Desk Reference, 48 Edition, pp. 2248-2250 (1994), "Dexedrine"
Hechtman, L., "Genetic and Neurobiological Aspects of Attention Deficit Hyperactive Disorder: A Review", J. Psychiatry Neurosci., vol. 19(3), pp. 193-201 (1994)
Merriam, et al., "Schizophrenia as a Neurobehavioral Disorder", Psychiatr. Annals., vol. 23 p. 178 (1993)
Pomerfeau, et al., "The Effects of Cigarette Smoking on Pain and Anxiety", Addictive Behavior, 9, p. 265 (1984)
Sanberg, et al., Proceedings from Intl. Symp. Nic., S39 (1994)
Vinson, D., "Therapy for Attention-Deficit Hyperactivity Disorder", Arch. Fam. Med., vol. 3(5), 445-451 (1994)
Wagner, et al., "Does Smoking Reduce the Risk of Neuroleptic Parkinsolnoids?", Pharmacopsychiatry, vol. 21, pp. 301-303 (1988)
Warburton, et al., "Cholinergic control of cognitive resources", Neuropsychobiology, Eds. Mendlewicz, et al., pp. 43-46 (1993)
Freedman, R. et al., Proceedings from Intl. Symp. Nic., S41 (1994
February 12, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
